After the detection of four anthrax cases in the US and
two in India, the manufacturers of anti-anthrax drug Ciprofloxacin
have started taking stock of their inventories to counter
any panic situation arising from the fear of the spread
of the disease through bio-terrorism.
When contacted, a Ranbaxy Laboratories spokesperson said
as the supply situation is normal and there has not been
any panic so far, the company, as a precautionary measure,
is reviewing the inventory position of Ciprofloxacin stocks.
that Ranbaxy did not have the US Food and Drug Administration
approval to market the drug in the US, the spokesperson
said its US subsidiary, Ranbaxy Pharmaceuticals, has been
asked by the authorities to review the inventory of Doxycyclin.
100 pharmaceutical companies are manufacturing copies
of Ciprofloxacin, a drug discovered by the German pharmaceutical
major Bayer. While the domestic market is led by Ranbaxy,
the other leading players include Cipla, Zydus Cadila
Healthcare, Dr Reddys Laboratories and Alkem, some of
whom are also believed to be gearing up to face any such
on the supply-side situation, All-India Organisation of
Chemists and Druggists vice-president Sandeep Nangia said
there is no shortage for anti-anthrax drugs as the supply
situation is normal. Nangia, who also heads the Delhi
Druggists and Chemists Association, said there is no chance
of hoarding of drugs by its members and asserted that
there is no panic in New Delhi. He said some companies
manufacturing Cipro are also in the process of checking
of anthrax occur every year in the country and some people
catch it from infected animals or eating their meat.
anthrax occurs among the countrys livestock, as animal
vaccination is in a dismal state. But what worries public
health experts is the rare and far more fatal form of
anthrax transmitted through spores that can be sprayed
from a plane or soaked in a filter paper and sent by post.
people died of the disease recently in Kolar district
Karnataka in an outbreak that killed quite a few animals.
The US, where anthrax cases after the September 11 terrorist
strikes have created quite a panic, has already sounded
an alert and launched a criminal probe into the incidents.